A detailed history of New Edge Advisors, LLC transactions in Senseonics Holdings, Inc. stock. As of the latest transaction made, New Edge Advisors, LLC holds 28,220 shares of SENS stock, worth $8,466. This represents 0.0% of its overall portfolio holdings.

Number of Shares
28,220
Previous 28,420 0.7%
Holding current value
$8,466
Previous $11,000 18.18%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$0.32 - $0.49 $64 - $98
-200 Reduced 0.7%
28,220 $9,000
Q2 2024

Aug 15, 2024

SELL
$0.37 - $0.52 $37 - $52
-100 Reduced 0.35%
28,420 $11,000
Q1 2024

May 14, 2024

SELL
$0.5 - $0.73 $500 - $730
-1,000 Reduced 3.39%
28,520 $15,000
Q4 2023

Feb 13, 2024

SELL
$0.48 - $0.7 $11,040 - $16,099
-23,000 Reduced 43.79%
29,520 $16,000
Q3 2023

Nov 14, 2023

BUY
$0.5 - $1.05 $1,500 - $3,150
3,000 Added 6.06%
52,520 $31,000
Q2 2023

Aug 14, 2023

BUY
$0.55 - $0.89 $49 - $80
90 Added 0.18%
49,520 $37,000
Q1 2023

May 12, 2023

SELL
$0.68 - $1.25 $4,420 - $8,125
-6,500 Reduced 11.62%
49,430 $35,000
Q4 2022

Feb 14, 2023

BUY
$0.96 - $1.34 $17,040 - $23,785
17,750 Added 46.49%
55,930 $57,000
Q3 2022

Nov 14, 2022

SELL
$1.02 - $2.23 $238 - $521
-234 Reduced 0.61%
38,180 $50,000
Q2 2022

Aug 09, 2022

BUY
$0.94 - $1.94 $10,020 - $20,680
10,660 Added 38.41%
38,414 $40,000
Q1 2022

May 13, 2022

BUY
$1.54 - $3.71 $6,483 - $15,619
4,210 Added 17.88%
27,754 $55,000
Q4 2021

Feb 17, 2022

SELL
$2.58 - $3.91 $32,391 - $49,090
-12,555 Reduced 34.78%
23,544 $63,000
Q3 2021

Oct 29, 2021

BUY
$2.77 - $4.05 $1,368 - $2,000
494 Added 1.39%
36,099 $122,000
Q2 2021

Jul 22, 2021

BUY
$1.71 - $4.14 $24,341 - $58,932
14,235 Added 66.61%
35,605 $137,000
Q1 2021

Apr 26, 2021

BUY
$0.85 - $5.27 $18,164 - $112,619
21,370 New
21,370 $56,000

Others Institutions Holding SENS

About Senseonics Holdings, Inc.


  • Ticker SENS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 465,447,008
  • Market Cap $140M
  • Description
  • Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with ...
More about SENS
Track This Portfolio

Track New Edge Advisors, LLC Portfolio

Follow New Edge Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New Edge Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on New Edge Advisors, LLC with notifications on news.